Comparison of Two Over the Counter Intravaginal Devices for the Treatment of Stress Urinary Incontinence
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT06698627
- Status
- Enrolling By Invitation
Conditions
- Stress Urinary Incontinence in Women
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Daily Disposable Continence Device — DEVICEThe Poise® Impressa® is an over-the-counter intravaginal device for women over the age of 21 years with SUI. It is a disposable, one-time use tampon-like device that comprises a core, cover, and applicator. The device is inserted and removed like a vaginal tampon and comes in three sizes.
- Monthly Disposable Continence Device — DEVICEThe Revive® is another over the counter vaginal insert for the treatment of SUI. This is a self-deployable, double-loop pessary device.
Study Details
The goal of this pilot study is to compare two commercially available over the counter devices for treatment of stress urinary incontinence in a web based format. The main questions it aims to answer 1. What device do women with SUI prefer after using both devices 2. What patient factors help drive this preference if any 3. Is a web-based crossover intervention study feasible Participants will: Use two over the counter devices over a course of 20 days. They will have both devices sent via mail. They will answer questions prior to the start of using any device and then after using each device They will be asked to complete daily bladder diaries
Key Dates
- Start date
- Jun 30, 2025
- Status verified
- Mar 2026
- Primary completion
- May 1, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Poise ImpressaParticipants will be asked to use Poise Impressa for 7 days based on package insert
- Active Comparator: ReviveParticipants will be asked to use Revive continence device based on package insert.
Primary Outcome Measure
Device Preference [ Time Frame: Day 10, Day 20 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37211 | - |